Alta Partners Management Company, L.P. Allakos Inc. Transaction History
Alta Partners Management Company, L.P.
- $41.8 Billion
- Q1 2025
A detailed history of Alta Partners Management Company, L.P. transactions in Allakos Inc. stock. As of the latest transaction made, Alta Partners Management Company, L.P. holds 2,546,147 shares of ALLK stock, worth $840,228. This represents 1.39% of its overall portfolio holdings.
Number of Shares
2,546,147
Previous 2,546,147
-0.0%
Holding current value
$840,228
Previous $3.08 Billion
81.19%
% of portfolio
1.39%
Previous 4.86%
Shares
1 transactions
Others Institutions Holding ALLK
# of Institutions
63Shares Held
61MCall Options Held
71.5KPut Options Held
19.8K-
Bvf Inc San Francisco, CA16.6MShares$5.46 Million0.17% of portfolio
-
Tang Capital Management LLC San Diego, CA8.69MShares$2.87 Million0.13% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.23MShares$2.39 Million0.06% of portfolio
-
Nea Management Company, LLC Timonium, MD6.15MShares$2.03 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.43MShares$1.13 Million0.0% of portfolio
About Allakos Inc.
- Ticker ALLK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,726,096
- Market Cap $28M
- Description
- Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...